E

EMBC

EMBC

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
100%Bullish
Buy/Sell Ratio100% buys
BearishBullish
EMBC Live QuoteReal-time
$6.02
$0.84(-12.24%)1M
Day Range$5.90 – $6.40
Open$5.97
Previous Close$6.19
Volume862.8K
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$335.99M
P/E Ratio (TTM)4.0
Forward P/ENaN
EPS (TTM)$1.47
Price to Book2.6
Dividend Yield7.55%
Beta (Volatility)0.81
IndustryMEDICAL INSTRUMENTS & SUPPLIES
52-Week RangeCurrent: $6.02 (28%)
Low: $2.76High: $14.31
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$4.00-97.3% upside

Insider Buys

1

$558K

Insider Sales

0

$0

Total Volume

$558K

1 transactions

Net Activity

+$558K

Net buying

Proprietary Ratings
Calculated from Form 4 transactions
65CONFIDENCE

Sentiment Rating

Moderate Accumulation

CEO Conviction Index

No Recent Signal

Key Drivers

  • •Strong buying bias: purchases represent 100% of total transaction value.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
M
1

Multiple Insiders

4 Insiders

1 buys0 sells

$558K total

Trading History
EMBC insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Aug 12, 2026

3 months ago

Multiple Insiders

4 Insiders

Insider
Buy115.0K$4.85$558K
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
EMBC Buy Conviction100%
Industry Rank#0 of 569
Volume Contribution0.0%
Total Industry Activity$16.52B

EMBC has an insider buy conviction of 100%, compared to the Unknown sector buy average of 6%.

Insider Trading Summary & Commentary
Automated executive transaction analysis for EMBC

Over the last 90 days, corporate insiders at EMBC (EMBC) engaged in a total of 1 transactions reported via SEC Form 4 filings. Among these, 1 were open-market purchases and 0 were sales. The total volume of insider trading reached $558K.

The net insider activity for EMBC shows a net buying bias of $558K. This activity represents a 100% buy ratio, suggesting that insiders are currently strongly bullish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Purchase by Multiple Insiders (4 Insiders), who traded 115.0K shares valued at $558K on Aug 12, 2026.

Live Market News & Developments
Aggregated real-time headlines for EMBC (EMBC)
6 updates

An insulin-delivery company will discuss preliminary 2027 guidance on Nov. 24.

Stock Titan3h ago

embecta to Host Fiscal Fourth Quarter and Full Year 2026 Financial Results Conference Call on November 24, 2026

Quiver Quantitative2h ago

Why Embecta Stock Plummeted Today

Yahoo Finance199d ago

EMBC - Embecta Corp Stock Price and Quote

Finviz177d ago

Deeply Undervalued Global Medical Device Company – Embecta Corp. (EMBC)

The Acquirer's Multiple197d ago

EMBC Stock Drop: Embecta Insulin Pen Issues Lead to 57% Stock Drop and Securities Fraud Class Action for Investors

PR Newswire108d ago

FAQs About EMBC Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for EMBC.

Based on SEC Form 4 disclosures, the Insider Confidence Score for EMBC is currently 65/100, which reflects a moderate accumulation bias. This calculation accounts for a total of 1 purchases and 0 sales by company executives over the last 90 days.

The CEO Conviction Index for EMBC is rated as "No Recent Signal". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.